穴位埋线治疗非酒精性脂肪性肝病中医实践指南

中华中医药学会肝胆病分会

doi:10.3969/j.issn.1001-5256.2022.09.008

穴位埋线治疗非酒精性脂肪性肝病中医实践指南

DOI: 10.3969/j.issn.1001-5256.2022.09.008

中华中医药学会肝胆病分会

基金项目:

河南省特色骨干学科中医学第二批学科建设项目 (STG-ZYX03-202120)

利益冲突声明：所有作者均声明不存在利益冲突。

通信作者：赵文霞，zhao-wenxia@163.com

计量
- 文章访问数: 532
- HTML全文浏览量: 114
- PDF下载量: 92
- 被引次数: 0
出版历程
- 收稿日期: 2022-08-24
- 录用日期: 2022-08-24
- 出版日期: 2022-09-20

Chinese medicine practice guide for acupoint catgut embedding in treating non-alcoholic fatty liver disease

Branch of Hepatobiliary Diseases, Chinese Association of Chinese Medicine

Research funding:

The Second Batch of Discipline Construction Project of Traditional Chinese Medicine in Henan Province (STG-ZYX03-202120)

摘要

- 非酒精性脂肪性肝病 /
- 穴位埋线 /
- 诊疗准则(主题)
- Non-Alcoholic Fatty Liver Disease /
- Catgut Embedding at Acupoints /
- Practice Guidelines as Topic

HTML全文

参考文献(31)

[1]	LIAO JL, HUANG WX, ZHANG DX, et al. Experimental study on catgut embedment in acupoint for non-alcoholic fatty liver disease[J]. Henan Tradit Chin Med, 2021, 41(1): 72-75. DOI: 10.16367/j.issn.1003-5028.2021.01.0019. 廖金玲, 黄文兴, 张丹璇, 等. 穴位埋线治疗非酒精性脂肪性肝病实验研究[J]. 河南中医, 2021, 41(1): 72-75. DOI: 10.16367/j.issn.1003-5028.2021.01.0019.
[2]	JIN LX, ZHOU Q, CHEN X. Clinical observation on treating nonalcoholic fatty liver disease by Lishi Quzhi Yin plus acupoint catgut embedding combined with western medicine[J]. Chin J Tradit Med Sci Technol, 2020, 27(5): 790-791. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYY202005054.htm 金玲肖, 周倩, 陈霞. 利湿祛脂饮加穴位埋线联合西药治疗非酒精性脂肪性肝病的临床观察[J]. 中国中医药科技, 2020, 27(5): 790-791. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYY202005054.htm
[3]	JIA WY, BAO GL. Treatment of 40 cases of nonalcoholic fatty liver by modified Danggui Shaoyao San combined with acupoint catgut embedding[J]. Guangming J Chin Med, 2020, 35(16): 2479-2481. DOI: 10.3969/j.issn.1003-8914.2020.16.018. 贾文燕, 包桂篮. 当归芍药散加味合穴位埋线治疗非酒精性脂肪肝40例[J]. 光明中医, 2020, 35(16): 2479-2481. DOI: 10.3969/j.issn.1003-8914.2020.16.018.
[4]	WANG J. Observation on therapeutic effect of acupoint catgut embedding on nonalcoholic fatty liver disease[J]. Lishizhen Med Mater Med Res, 2015, 26(3): 654-655. DOI: 10.3969/j.issn.1008-0805.2015.03.055. 王俊. 穴位埋线治疗非酒精性脂肪性肝病的疗效观察[J]. 时珍国医国药, 2015, 26(3): 654-655. DOI: 10.3969/j.issn.1008-0805.2015.03.055.
[5]	XIONG ZK. Effect of self-designed Lishi Xingshui decoction combined with acupoint embedding on non-alcoholic fatty liver disease and its influence on imaging indicators[J]. Mod J Integr Tradit Chin West Med, 2020, 29(9): 950-953. DOI: 10.3969/j.issn.1008-8849.2020.09.009. 熊哲锟. 自拟利湿行水方合穴位埋线治疗非酒精性脂肪性肝病疗效观察[J]. 现代中西医结合杂志, 2020, 29(9): 950-953. DOI: 10.3969/j.issn.1008-8849.2020.09.009.
[6]	CHEN S, LUO S, LIANG CH. 50 cases of non-alcoholic fatty liver disease treated with traditional Chinese medicine combined with catgut embedding[J]. Jiangxi J Tradit Chin Med, 2015, 46(6): 34-35. https://www.cnki.com.cn/Article/CJFDTOTAL-JXZY201506016.htm 陈姗, 罗莎, 梁彩虹. 中药联合穴位埋线治疗非酒精性脂肪性肝病50例[J]. 江西中医药, 2015, 46(6): 34-35. https://www.cnki.com.cn/Article/CJFDTOTAL-JXZY201506016.htm
[7]	YAN XY, REN X, WANG JQ, et al. Observations on the efficacy of acupoint catgut embedding plus Chinese Herbal Medicine for nonalcoholic fatty liver disease[J]. Shanghai J Acupunct Moxib, 2020, 39(2): 173-178. DOI: 10.13460/j.issn.1005-0957.2020.02.0173. 阎晓悦, 任鑫, 王京奇, 等. 穴位埋线联合中药治疗非酒精性脂肪性肝病疗效观察[J]. 上海针灸杂志, 2020, 39(2): 173-178. DOI: 10.13460/j.issn.1005-0957.2020.02.0173.
[8]	ZHOU XL, TANG N, WU T, et al. Mechanism of catgut embedding at back-shu points for nonalcoholic steatohepatitis based on IKK/IKB/NF-κB signaling pathway[J]. Chin Acupunct Moxibust, 2020, 40(1): 59-66. DOI: 10.13703/j.0255-2930.20181204-0002. 周晓玲, 唐农, 吴腾, 等. 基于IKK/IKB/NF-κB信号通路背俞穴埋线治疗非酒精性脂肪性肝炎的机制研究[J]. 中国针灸, 2020, 40(1): 59-66. DOI: 10.13703/j.0255-2930.20181204-0002.
[9]	CHEN W, FANG SN, LIU JP. Recommendations for clinical evidence grading on traditional Chinese medicine based on evidence body[J]. Chin J Integr Trad West Med, 2019, 39(3): 358-364. DOI: 10.7661/j.cjim.20190123.062. 陈薇, 方赛男, 刘建平. 基于证据体的中医药临床证据分级标准建议[J]. 中国中西医结合杂志, 2019, 39(3): 358-364. DOI: 10.7661/j.cjim.20190123.062.
[10]	Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on TCM diagnosis and treatment of nonalcoholic fatty liver disease (2017)[J]. J Clin Hepatol, 2017, 33(12): 2270-2274. DOI: 10.3969/j.issn.1001-5256.2017.12.002. 中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗专家共识意见(2017)[J]. 临床肝胆病杂志, 2017, 33(12): 2270-2274. DOI: 10.3969/j.issn.1001-5256.2017.12.002.
[11]	LI YF, XIE DM, YAO LH, et al. Clinical study of acupoint minimally invasive catgut embedding in the treatment of non-alcoholic fatty liver disease[J]. Chin J Integr Tradit West Med Liver Dis, 2019, 29(6): 550-551, 558. DOI: 10.3969/j.issn.1005-0264.2019.06.025. 李永丰, 谢冬梅, 姚立红, 等. 穴位微创埋线治疗非酒精性脂肪性肝病的临床研究[J]. 中西医结合肝病杂志, 2019, 29(6): 550-551, 558. DOI: 10.3969/j.issn.1005-0264.2019.06.025.
[12]	CHEN ZR. Clinical study on acupoint embedding therapy for simple obesity complicated with fatty liver[D]. Hefei: Anhui University of Chinese Medicine, 2018. 陈志蕊. 穴位埋线治疗单纯性肥胖合并脂肪肝的临床研究[D]. 合肥: 安徽中医药大学, 2018.
[13]	LI JJ. Clinical study on acupoint catgut embedding plus electroacupuncture in treating nonalcoholic fatty liver[D]. Nanning: Guangxi University of Traditional Chinese Medicine, 2020. 李靖杰. 穴位埋线加电针治疗非酒精性脂肪肝的临床研究[D]. 南宁: 广西中医药大学, 2020.
[14]	HUANG Z, SONG SL, TAN KP, et al. Observation on clinical effects of acupoint thread-embedding method for non-alcoholic fatty liver disease[J]. J Acupunct Tuina Sci, 2016, 14(3): 186-191. DOI: 10.1007/s11726-016-0922-6.
[15]	HUANG Z, SONG SL, TAN KP, et al. Non-alcoholic fatty liver disease of liver stagnation and spleen deficiency pattern treated with acupoint embedding therapy: a randomized controlled trial[J]. Chin Acupunct Moxibust, 2016, 36(2): 119-123. DOI: 10.13703/j.0255-2930.2016.02.002. 黄振, 宋双临, 谭克平, 等. 穴位埋线治疗肝郁脾虚型非酒精性脂肪性肝病: 随机对照研究[J]. 中国针灸, 2016, 36(2): 119-123. DOI: 10.13703/j.0255-2930.2016.02.002.
[16]	ZHOU ZQ, FANG MH, XU WT. Non-alcoholic fatty liver disease of liver stagnation and spleen deficiency pattern treated with acupoint embedding therapy: a randomized controlled trial[J]. Mod J Integr Tradit Chin West Med, 2021, 30(9): 944-948, 966. DOI: 10.13703/j.0255-2930.2016.02.002. 周自强, 方妹辉, 徐文婷. 降脂方联合穴位埋线治疗非酒精性脂肪性肝炎疗效观察[J]. 现代中西医结合杂志, 2021, 30(9): 944-948, 966. DOI: 10.13703/j.0255-2930.2016.02.002.
[17]	HE AN, XIONG ZF, LI HC, et al. Observation on therapeutic effect of acupoint catgut embedding combined with Qihe decoction on nonalcoholic steatohepatitis[J]. Lishizhen Med Mater Med Res, 2019, 30(1): 112-113. DOI: 10.3969/j.issn.1008-0805.2019.01.035. 贺安妮, 熊振芳, 李华成, 等. 穴位埋线联合杞荷饮治疗非酒精性脂肪性肝炎疗效观察[J]. 时珍国医国药, 2019, 30(1): 112-113. DOI: 10.3969/j.issn.1008-0805.2019.01.035.
[18]	LU LR, HUANG Z. Ultrasonographic evaluation of the efficacy of acupoint catgut embedding plus medication for nonalcoholic fatty liver disease[J]. Shanghai J Acupunct Moxib, 2014, 33(11): 1016-1017. DOI: 10.13460/j.issn.1005-0957.2014.11.1016. 卢利仁, 黄振. 超声评价穴位埋线配合药物治疗非酒精性脂肪性肝病的疗效[J]. 上海针灸杂志, 2014, 33(11): 1016-1017. DOI: 10.13460/j.issn.1005-0957.2014.11.1016.
[19]	GU YJ, ZHAO WX. Effect of acupoint catgut embedding on blood lipids in 40 patients with nonalcoholic fatty liver disease[J]. Chin Med Modern Distance Educ of China, 2013, 11(19): 82-83. DOI: 10.3969/j.issn.1672-2779.2013.19.058. 顾亚娇, 赵文霞. 穴位埋线对非酒精性脂肪性肝病患者血脂影响观察40例[J]. 中国中医药现代远程教育, 2013, 11(19): 82-83. DOI: 10.3969/j.issn.1672-2779.2013.19.058.
[20]	LIANG BJ, SHEN WZ, LIAO SR. Observation on therapeutic effect of acupoint catgut embedding combined with Chinese medicine for soothing liver and resolving phlegm on nonalcoholic fatty liver disease[J]. Shanxi J Tradit Chin Med, 2019, 35(4): 36-37. DOI: 10.3969/j.issn.1000-7156.2019.04.018. 梁炳君, 沈维增, 廖圣榕. 穴位埋线联合疏肝化痰中药治疗非酒精性脂肪肝病疗效观察[J]. 山西中医, 2019, 35(4): 36-37. DOI: 10.3969/j.issn.1000-7156.2019.04.018.
[21]	ZHANG Y. The clinical efficacy and mechanismof "Qiang Gan Xiao Zhi" prescription combined with acupoint embedding in the treatment of non-alcoholic fatty hepatitis[D]. Nanning: Guangxi University of Chinese Medicine, 2018. 张悦. 强肝消脂饮联合穴位埋线治疗非酒精性脂肪性肝炎临床疗效及机制研究[D]. 南宁: 广西中医药大学, 2018.
[22]	OU ZJ. Clinical observation of acupoint catgut embedding combined with behavior control on obese nonalcoholic fatty liver disease[D]. Nanjing: Nanjing University of Chinese Medicine, 2020. 欧增健. 穴位埋线结合行为控制对肥胖型非酒精性脂肪性肝病临床疗效观察[D]. 南京: 南京中医药大学, 2020.
[23]	BOHTE AE, van WERVEN JR, BIPAT S, et al. The diagnostic accuracy of US, CT, MRI and ¹H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis[J]. Eur Radiol, 2011, 21(1): 87-97. DOI: 10.1007/s00330-010-1905-5.
[24]	BEDOSSA P, FLIP Pathology Consortium. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease[J]. Hepatology, 2014, 60(2): 565-575. DOI: 10.1002/hep.27173.
[25]	WANG XX. Clinical observation on acupoint catgut embedding therapy for obesity patients with nonalcoholic fatty liver[D]. Urumqi: Xinjiang Medical University, 2013. 王鑫欣. 穴位埋线治疗非酒精性脂肪肝肥胖患者的临床观察[D]. 乌鲁木齐: 新疆医科大学, 2013.
[26]	YANG W, ZHOU XL, LIU J. et al. Clinical curative effect exploration of non-alcoholic fatty liver disease of moisture turbidity stopping type treat with catgut implantation based on the infrared thermal imaging technology[J]. J Liaoning Univ Tradit Chin Med, 2019, 21(5): 118-122. DOI: 10.13194/j.issn.1673-842x.2019.05.031. 杨薇, 周晓玲, 刘静, 等. 基于医用红外热成像技术评价穴位埋线对湿浊内停型非酒精性脂肪性肝病临床疗效观察[J]. 辽宁中医药大学学报, 2019, 21(5): 118-122. DOI: 10.13194/j.issn.1673-842x.2019.05.031.
[27]	SHEN F, ZHENG RD, MI YQ, et al. Value of a two-step approach with cytokeratin-18 and controlled attenuation parameter in noninvasive differential diagnosis of nonalcoholic steatohepatitis[J]. Chin J Hepatol, 2016, 24(6): 429-434. DOI: 10.3760/cma.j.issn.1007-3418.2016.06.007 沈峰, 郑瑞丹, 宓余强, 等. 细胞角蛋白-18联合受控衰减参数二步法无创鉴别非酒精性脂肪性肝炎的临床研究[J]. 中华肝脏病杂志, 2016, 24(6): 429-434. DOI: 10.3760/cma.j.issn.1007-3418.2016.06.007
[28]	ZHOU XL, XIE S, HOU QK. Effect of catgut implantation on serum leptin and insulin resistance of nonalcoholic fatty liver disease[J]. J Liaoning Univ Tradit Chin Med, 2012, 14(2): 58-59. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201202022.htm 周晓玲, 谢胜, 侯秋科. 背俞穴穴位埋线对非酒精性脂肪肝血清瘦素水平及胰岛素抵抗指数的影响[J]. 辽宁中医药大学学报, 2012, 14(2): 58-59. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201202022.htm
[29]	DAI L, OOI VV, ZHOU W, et al. Acupoint embedding therapy improves nonalcoholic fatty liver disease with abnormal transaminase: A PRISMA-compliant systematic review and meta-analysis[J]. Medicine (Baltimore), 2020, 99(3): e18775. DOI: 10.1097/MD.0000000000018775.
[30]	HUANG HN, HUANG JJ, MAO DW, et al. Clinical study on Baliao acupoint catgut embedding combined with Quyu Huazhuo decoction in treating nonalcoholic steatohepatitis[J]. Mod J Integr Tradit Chin West Med, 2017, 26(3): 272-274. DOI: 10.3969/j.issn.1008-8849.2017.03.014. 黄鸿娜, 黄晶晶, 毛德文, 等. 八髎穴埋线联合祛瘀化浊汤治疗非酒精性脂肪性肝炎的临床研究[J]. 现代中西医结合杂志, 2017, 26(3): 272-274. DOI: 10.3969/j.issn.1008-8849.2017.03.014.
[31]	LYU XR. Clinical study on the treatment of simple obesity and its effect on blood lipid by acupoint catgut embedding[D]. Zhengzhou: Henan College of Traditional Chinese Medicine, 2009. 吕晓蕊. 透穴埋线法治疗单纯性肥胖症及对血脂影响的临床研究[D]. 郑州: 河南中医学院, 2009.